SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients
1 other identifier
observational
1,701
1 country
1
Brief Summary
The purpose of this study is to characterize the chronic performance of the St. Jude Medical SJ4 connector and RV high voltage SJ4 leads.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
July 14, 2009
CompletedFirst Posted
Study publicly available on registry
July 16, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedResults Posted
Study results publicly available
August 14, 2017
CompletedFebruary 4, 2019
January 1, 2019
6.3 years
July 14, 2009
January 12, 2017
January 31, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Right Ventricle (RV) Bipolar Capture Thresholds
5 years
Complication Free Survival Rate Related to the High Voltage RV SJ4 Lead or SJ4 Connector
5 years
Study Arms (1)
No treatment: ICD/CRTD-indicated
Interventions
Standard of care implantation of SJ4 device system
Eligibility Criteria
ICD and CRTD indicated patients
You may qualify if:
- Have an approved indication per ACC/AHA/HRS guidelines for implantation of heart failure or life-threatening ventricular tachyarrhythmias and will be implanted with a St. Jude Medical SJ4 system.
- Have the ability to provide informed consent for study participating and be willing and able to comply with the prescribed follow-up test and schedule of evaluations.
You may not qualify if:
- Be currently participating in a clinical investigation that includes an active treatment arm.
- Have a life expectancy of less than 6 months due to any condition.
- Be less than 18 years of age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Grant Kim, Director Clinical Studies
- Organization
- Saint Jude Medical
Study Officials
- PRINCIPAL INVESTIGATOR
Bruce Wilkoff, MD
The Clevleland Clinic Foundation
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2009
First Posted
July 16, 2009
Study Start
June 1, 2009
Primary Completion
September 1, 2015
Study Completion
December 1, 2015
Last Updated
February 4, 2019
Results First Posted
August 14, 2017
Record last verified: 2019-01
Data Sharing
- IPD Sharing
- Will not share